Published in Drug Law Weekly, March 4th, 2008
All 170 employees currently at the 215,000-square-foot facility received offer letters from Genmab today contingent on successful closing of the purchase.
Genmab focuses on developing fully human antibody therapeutics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.